Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

February
11
2022

Report on Skin Aging reduction treatment through Dermoelectroporation

Dr. Gabriela Vasilescu, M.D.   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of an Hydrating cocktail for skin aging treatment through Dermoelectroporation®. Study Design 5 sessions in total. 1 sitting…

February
10
2022

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA…

February
10
2022

Report on Inner Arm excess skin relaxation treatment through Dermoelectroporation

Dr. A.Gessati*, *Aesthetic medicine Doctor, Milan, Italy.   Preliminary Study Dermoelectroporation, well known and established method for transdermal substances delivery without the use of needles, allows to get to important results for skin imperfection conditions,…

February
10
2022

Report on Hyaluronic Acid & Oligopeptides cocktail treatments through Dermoelectroporation

Dr. James Fulton, vivant Skin Care , Miami Florida, USA   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a Hyaluronic Acid & Oligopeptides cocktail for either facial lifting and…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry